• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血栓形成倾向的评估:抗凝血酶(AT)检测的性能

Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.

作者信息

Gausman Jana N, Marlar Richard A

机构信息

Pathology and Laboratory Medicine Service, Oklahoma City VA Medical Center, Oklahoma City, OK, USA.

Department of Pathology, University of New Mexico, Albuquerque, NM, 87131, USA.

出版信息

Methods Mol Biol. 2017;1646:161-167. doi: 10.1007/978-1-4939-7196-1_13.

DOI:10.1007/978-1-4939-7196-1_13
PMID:28804827
Abstract

Antithrombin (AT) is a naturally occurring plasma inhibitor of coagulation, which is a synthesized in the liver. AT inhibits coagulation serine proteases (the enzymatically activated forms of the clotting factors), mainly thrombin (factor IIa) and factor Xa, but also to a lesser extent factors IXa, XIa, and XIIa. Acting alone, AT inhibits coagulation factors, but does this very slowly; however, when coupled with heparin as a cofactor, the speed of inhibition is increased many fold. The AT/Heparin complex is the most powerful naturally occurring anticoagulant in blood. AT levels of <70% of normal can cause significant thrombosis. Low levels of AT are caused by inherited genetic defects or acquired causes from other disease states. Plasma AT levels can be determined using a chromogenic assay with either bovine thrombin or human factor Xa as the enzyme. The generated color generated in the assay is inversely proportional to the concentration of AT in the plasma.

摘要

抗凝血酶(AT)是一种天然存在的血浆凝血抑制剂,由肝脏合成。AT抑制凝血丝氨酸蛋白酶(凝血因子的酶促活化形式),主要是凝血酶(因子IIa)和因子Xa,但在较小程度上也抑制因子IXa、XIa和XIIa。单独作用时,AT抑制凝血因子,但作用非常缓慢;然而,当与肝素作为辅因子结合时,抑制速度会提高许多倍。AT/肝素复合物是血液中最强大的天然抗凝剂。AT水平低于正常水平的70%可导致显著血栓形成。AT水平低是由遗传缺陷或其他疾病状态的后天原因引起的。血浆AT水平可以使用以牛凝血酶或人因子Xa作为酶的发色测定法来确定。测定中产生的颜色与血浆中AT的浓度成反比。

相似文献

1
Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.遗传性血栓形成倾向的评估:抗凝血酶(AT)检测的性能
Methods Mol Biol. 2017;1646:161-167. doi: 10.1007/978-1-4939-7196-1_13.
2
Antithrombin.抗凝血酶
Methods Mol Biol. 2013;992:355-64. doi: 10.1007/978-1-62703-339-8_28.
3
Activation of blood coagulation at heparin-coated surfaces.肝素包被表面上血液凝固的激活。
J Biomed Mater Res. 1997 Oct;37(1):108-13. doi: 10.1002/(sici)1097-4636(199710)37:1<108::aid-jbm13>3.0.co;2-c.
4
Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.重新审视抗凝血酶在健康与疾病、先天性缺陷和基因变异以及α和β形式的实验室研究中的作用。
Transfus Apher Sci. 2018 Apr;57(2):291-297. doi: 10.1016/j.transci.2018.04.010. Epub 2018 Apr 19.
5
Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.合成寡糖对凝血和纤维蛋白溶解系统蛋白酶抗凝血酶抑制作用的加速能力。与肝素和低分子肝素的比较。
Thromb Haemost. 2004 Nov;92(5):929-39. doi: 10.1160/TH04-06-0384.
6
Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.抗凝血酶β-折叠C的第3条链中的酪氨酸253和谷氨酸255残基是一个外位点的关键决定因素,该外位点通过肝素激活变得可及,以促进对因子Xa和IXa的快速抑制。
J Biol Chem. 2006 May 12;281(19):13424-13432. doi: 10.1074/jbc.M600415200. Epub 2006 Mar 3.
7
Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era.在 DOAC 时代的血栓形成倾向检查中,基于活化因子 X 的抗凝血酶检测与基于凝血酶的抗凝血酶检测。
Thromb Haemost. 2018 Feb;118(2):381-387. doi: 10.1160/TH17-08-0568. Epub 2018 Jan 29.
8
Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.肝素及类肝素分子在血栓形成和动脉粥样硬化中的作用。
Fed Proc. 1985 Feb;44(2):404-9.
9
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.抗凝血酶对凝血酶、因子Xa、因子IXa、因子XIa、因子XIIa和激肽释放酶抑制作用中,肝素促速率效应的分子量依赖性。
Biochem J. 1981 Feb 1;193(2):395-400. doi: 10.1042/bj1930395.
10
Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.遗传性血栓形成倾向的评估:蛋白C(PC)检测的性能
Methods Mol Biol. 2017;1646:145-151. doi: 10.1007/978-1-4939-7196-1_11.

引用本文的文献

1
Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.止血与血栓形成:概述,重点介绍相关实验室检测,以诊断和帮助管理相关疾病。
Methods Mol Biol. 2023;2663:3-38. doi: 10.1007/978-1-0716-3175-1_1.
2
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency.导致先天性抗凝血酶缺乏症的两个SERPINC1突变的鉴定与特征分析
Thromb J. 2023 Jan 9;21(1):3. doi: 10.1186/s12959-022-00443-6.
3
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics.
通过监测凝血酶抑制动力学对抗凝血酶突变进行功能表征。
Int J Mol Sci. 2021 Feb 20;22(4):2119. doi: 10.3390/ijms22042119.